Bracanat Olaparib Tablet 100mg, Natco

Get a Price/Quote

Bracanat Olaparib Tablet 100mg, Natco Specification

Life Span
Refer to expiry date on pack

Origin of Medicine
India

Salt Composition
Olaparib 100 mg

Indication
Indicated for use in cancers such as ovarian and breast cancer with BRCA mutation

Brand Name
Bracanat

Packaging Type
Bottle and external box

Pacakaging (Quantity Per Box)
30 Tablets

Dosage Form
Oral tablet

Drug Type
Prescription

Ingredients
Olaparib

Physical Form
Tablet

Function
Antineoplastic (anti-cancer)

Recommended For
Patients with specific types of ovarian, breast, fallopian tube, or peritoneal cancer

Dosage
100 mg per tablet

Dosage Guidelines
As directed by the physician

Suitable For
Adults

Quantity
30 Tablets per bottle

Storage Instructions
Store below 30C, keep container tightly closed and dry

Strength
100 mg

Prescription Required
Yes

Safety Information
Keep out of reach of children. Use under medical supervision only

Marketed By
Natco Pharma Ltd.

Warning
To be sold by retail on the prescription of an oncologist only

Product Category
Anticancer medicine

Primary Use
PARP inhibitor for oncology

Registration Status
Marketed product

Color
White

Shape
Oval

Administration Route
Oral

About Bracanat Olaparib Tablet 100mg, Natco

Bracanat Olaparib Tablet 100mg by Natco Pharma Ltd. is a top-tier prescription anticancer medicine, renowned as a best-seller in oncology care. Highlighted for its astonishing efficacy as a PARP inhibitor, it's perfect for adult patients with specific ovarian, breast, fallopian tube, or peritoneal cancers with BRCA mutation. Each white, oval-shaped tablet delivers 100 mg of Olaparib in a convenient oral form. Securely packaged in bottles of 30, Bracanat offers trusted strength and reliability, requiring strict medical supervision for safe usage. Offer available by prescription only.

Targeted Application in Oncology

Bracanat Olaparib Tablet 100mg is expertly indicated for use in adults dealing with ovarian, breast, fallopian tube, or peritoneal cancers linked to the BRCA mutation. This product works as a potent PARP inhibitor, disrupting cancer cell growth and helping to manage challenging oncological conditions. Its targeted mechanism makes it suitable only for patients as recommended by oncologists, ensuring optimal effect in the indicated application areas within oncology.

Packaging, Supply Ability, and Market Exchange

Packaged securely in bottles, each containing 30 tablets, Bracanat Olaparib Tablet 100mg is distributed to both the domestic market and major international export destinations. Supplied under rigorous certifications and in compliance with safety standards, its availability is streamlined via authorized channels. The product's packaging and export quality are designed to meet global pharmaceutical standards, ensuring effective supply exchange to the markets needing advanced cancer therapeutics.

FAQ's of Bracanat Olaparib Tablet 100mg, Natco:

Q: How should Bracanat Olaparib Tablet 100mg be taken?

A: Bracanat Olaparib Tablet should be taken orally, following the dosage guidelines directed by your physician or oncologist. Adhering to your prescribed schedule ensures the best outcomes.

Q: What conditions is Bracanat Olaparib 100mg specifically recommended for?

A: This medicine is recommended for adult patients with specific ovarian, breast, fallopian tube, or peritoneal cancers that have a BRCA mutation, as certified by your oncologist.

Q: When should I consult my doctor while using Bracanat Olaparib?

A: You should consult your doctor immediately if you experience any unusual symptoms, have concerns during treatment, or before making any changes to your dose or schedule.

Q: Where is Bracanat Olaparib 100mg manufactured and marketed?

A: Bracanat Olaparib 100mg is manufactured and marketed by Natco Pharma Ltd. in India, and distributed both domestically and to international markets.

Q: What safety precautions should be followed with this medication?

A: Store the tablets below 30C in a tightly closed container, keep out of reach of children, and use only under medical supervision. Follow your doctor's and pharmacist's instructions for optimal safety.

Q: How does Bracanat Olaparib tablet benefit patients?

A: As a PARP inhibitor, Bracanat Olaparib targets cancer cells, helping to slow disease progression and offering an advanced treatment option for patients with specific BRCA-mutated cancers.

Tell us about your requirement